Delek US (DK) EVP reports equity awards and tax-withholding shares

Rhea-AI Filing Summary

Delek US Holdings EVP Robert G. Wright reported routine equity compensation activity. On March 10, 2026, he acquired 12,934 shares of common stock at no cost upon vesting of performance-based restricted stock units and received a separate grant of 3,075 time-vesting restricted stock units that vest over three years.

On the same date, 9,562 shares were withheld at a price of $40.64 per share to cover tax obligations related to these equity awards, rather than being sold on the open market. After these transactions, Wright directly owned 58,868 shares of Delek US Holdings common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wright Robert G.

(Last) (First) (Middle)

310 SEVEN SPRINGS WAY

SUITE 500

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		A(1)		12,934	A	$0	65,355	D
Common Stock	03/10/2026		A(2)		3,075	A	$0	68,430	D
Common Stock	03/10/2026		F(3)		9,562	D	$40.64	58,868	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares delivered upon the vesting of performance based restricted stock units.

2. Represents a grant of time-vesting restricted stock units that vest over three years.

3. Represents shares withheld for tax purposes upon vesting of equity awards.

Remarks:

	/s/ Misty Lavender, Attorney in Fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Delek US (DK) EVP Robert G. Wright report?

Robert G. Wright reported routine equity compensation activity. On March 10, 2026, he received performance-based and time-vesting restricted stock unit awards and had shares withheld to satisfy tax obligations related to these vestings.

How many Delek US (DK) shares did Robert G. Wright acquire in the latest Form 4?

He acquired 12,934 shares upon vesting of performance-based restricted stock units and received an additional grant of 3,075 time-vesting restricted stock units. Both awards were reported at a price of zero per share as compensation, not open-market purchases.

Why were 9,562 Delek US (DK) shares disposed of in Robert G. Wright’s Form 4?

The 9,562 shares were withheld at $40.64 per share to cover tax liabilities on vested equity awards. This Form 4 labels the transaction with code F, indicating a tax-withholding disposition rather than an open-market sale by the executive.

What is Robert G. Wright’s Delek US (DK) share ownership after these transactions?

Following the March 10, 2026 transactions, Robert G. Wright directly owned 58,868 shares of Delek US Holdings common stock. This reflects his position after receiving new restricted stock units and having some shares withheld for tax obligations.

Were the Delek US (DK) insider transactions open-market buys or sells?

No open-market buys or sells were reported. The Form 4 shows equity compensation grants (code A) at zero cost and a tax-withholding disposition (code F). These transactions relate to restricted stock unit vesting and associated tax payments, not trading decisions.